易普利姆玛
无容量
医学
黑色素瘤
免疫疗法
无症状的
临床试验
肿瘤科
转移性黑色素瘤
内科学
脑转移
癌症研究
癌症
转移
作者
Mario Mandalá,Paul Lorigan,Maria Chiara Sergi,Naima Benannoune,Patricio Serra,Maria Grazia Vitale,Diana Giannarelli,Ana Arance,Eva Muñoz‐Couselo,Bart Neyns,Marco Tucci,Michele Guida,Francesco Spagnolo,Ernesto Rossi,Marcella Occelli,Paola Queirolo,Pietro Quaglino,Roberta Depenni,Barbara Merelli,Joanna Placzke
标识
DOI:10.1016/j.ejca.2024.113542
摘要
Ipilimumab plus nivolumab (COMBO) is the standard treatment in asymptomatic patients with melanoma brain metastases (MBM). We report a retrospective study aiming to assess the outcome of patients with MBM treated with COMBO outside clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI